New optical biosensor system may help round-the-clock management of gout

Dr. Mike McShane and his research team from the Center for Remote Health Technologies and Systems have created a minimally invasive biosensor system that may hold the key to future point-of-care therapies centered around personal management of gout, and possibly other conditions. Patients with gout tend to have higher levels of urate salts circulating in their bloodstreams, a condition called hyperuricemia. Levels of circulating urate can be kept in check with medications, and McShane’s biosensor system further allows patients to measure their urate levels precisely and personally manage the disease.

Read the full article by the Texas A&M University College of Engineering